论文部分内容阅读
目的探讨卒中单元治疗模式对急性脑血管病(ACVD)的效果。方法将符合标准的673例ACVD患者分为卒中单元治疗组(385例)及常规治疗组(288例)进行治疗。比较分析两组住院病死率、合并症发生率、近期临床疗效以及NIHSS、BI、OHS的差异。结果尽管两组在住院病死率上差异无统计学意义,但A组在近期临床疗效方面及NIHSS(3.51±4.46VS4.76±7.33)、BI(84.31±21.60VS79.46±16.70)、OHS(1.27±1.31VS1.55±1.12)等评分上均明显优于B组(P<0.01),合并症发生率两组为24.14%VS31.60%,A组显著低于B组(P<0.01)。结论卒中单元医疗模式治疗ACVD有确切疗效,它能明显提高治愈率、减少并发症和致残率,提高患者的生活质量,是适合我国的ACVD的治疗模式。
Objective To investigate the effect of stroke unit therapy on acute cerebrovascular disease (ACVD). Methods A total of 673 ACVD patients were divided into stroke unit treatment group (385 cases) and conventional treatment group (288 cases). The in-hospital mortality, the incidence of comorbidities, the recent clinical efficacy, NIHSS, BI and OHS were compared between the two groups. Results Although there was no significant difference in in-hospital mortality between the two groups, the clinical efficacy of NIHSS (3.51 ± 4.46 VS4.76 ± 7.33), BI (84.31 ± 21.60 VS79.46 ± 16.70) and OHS 1.27 ± 1.31VS1.55 ± 1.12) were significantly superior to those in group B (P <0.01). The incidence of comorbidity was 24.14% VS31.60% in both groups, significantly lower in group A than in group B (P <0.01) . Conclusion Stroke unit medical treatment of ACVD has the exact effect, which can significantly improve the cure rate, reduce complications and disability rate and improve the quality of life of patients, is suitable for our country ACVD treatment mode.